Hillsdale Investment Management’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.44M | Buy |
6,810
+1,050
| +18% | +$226K | 0.04% | 324 |
|
|
2025
Q4 | $1.18M | Buy |
5,760
+50
| +0.9% | +$9.41K | 0.03% | 341 |
|
|
2025
Q3 | $896K | Buy |
5,710
+900
| +19% | +$139K | 0.03% | 380 |
|
|
2025
Q2 | $808K | Buy |
+4,810
| New | +$714K | 0.03% | 337 |
|
|
2024
Q4 | – | Sell |
-7,840
| Closed | -$866K | – | 592 |
|
|
2024
Q3 | $866K | Buy |
7,840
+1,200
| +18% | +$125K | 0.07% | 236 |
|
|
2024
Q2 | $653K | Hold |
6,640
| – | – | 0.05% | 250 |
|
|
2024
Q1 | $743K | Hold |
6,640
| – | – | 0.06% | 229 |
|
|
2023
Q4 | $669K | Hold |
6,640
| – | – | 0.05% | 228 |
|
|
2023
Q3 | $576K | Buy |
6,640
+1,100
| +20% | +$99.4K | 0.05% | 227 |
|
|
2023
Q2 | $524K | Hold |
5,540
| – | – | 0.05% | 230 |
|
|
2023
Q1 | $418K | Buy |
+5,540
| New | +$418K | 0.04% | 364 |
|
|
2021
Q1 | – | Sell |
-600
| Closed | -$32K | – | 547 |
|
|
2020
Q4 | $32K | Buy |
+600
| New | +$31.1K | ﹤0.01% | 466 |
|
|
2020
Q3 | – | Sell |
-8,355
| Closed | -$436K | – | 582 |
|
|
2020
Q2 | $436K | Sell |
8,355
-800
| -9% | -$41.2K | 0.04% | 348 |
|
|
2020
Q1 | $438K | Buy |
+9,155
| New | +$475K | 0.05% | 312 |
|
|
2019
Q2 | – | Sell |
-400
| Closed | -$19K | – | 604 |
|
|
2019
Q1 | $19K | Buy |
+400
| New | +$20K | ﹤0.01% | 471 |
|
|
2017
Q3 | – | Sell |
-100
| Closed | -$8K | – | 478 |
|
|
2017
Q2 | $8K | Sell |
100
-10
| -9% | -$755 | ﹤0.01% | 345 |
|
|
2017
Q1 | $9K | Hold |
110
| – | – | ﹤0.01% | 357 |
|
|
2016
Q4 | $8K | Sell |
110
-700
| -86% | -$50.6K | ﹤0.01% | 364 |
|
|
2016
Q3 | $63K | Sell |
810
-3,600
| -82% | -$291K | 0.02% | 325 |
|
|
2016
Q2 | $344K | Sell |
4,410
-500
| -10% | -$39.9K | 0.1% | 226 |
|
|
2016
Q1 | $403K | Sell |
4,910
-40
| -0.8% | -$3.25K | 0.14% | 152 |
|
|
2015
Q4 | $442K | Hold |
4,950
| – | – | 0.17% | 105 |
|
|
2015
Q3 | $380K | Hold |
4,950
| – | – | 0.13% | 149 |
|
|
2015
Q2 | $414K | Buy |
4,950
+900
| +22% | +$79.5K | 0.13% | 148 |
|
|
2015
Q1 | $366K | Buy |
4,050
+3,900
| +2,600% | +$336K | 0.09% | 198 |
|
|
2014
Q4 | $12K | Hold |
150
| – | – | ﹤0.01% | 483 |
|
|
2014
Q3 | $11K | Hold |
150
| – | – | ﹤0.01% | 484 |
|
|
2014
Q2 | $10K | Hold |
150
| – | – | ﹤0.01% | 489 |
|
|
2014
Q1 | $10K | Hold |
150
| – | – | ﹤0.01% | 481 |
|
|
2013
Q4 | $10K | Sell |
150
-5,400
| -97% | -$330K | ﹤0.01% | 471 |
|
|
2013
Q3 | $289K | Buy |
5,550
+5,400
| +3,600% | +$274K | 0.09% | 214 |
|
|
2013
Q2 | $7K | Buy |
+150
| New | +$6.85K | ﹤0.01% | 484 |
|
Other funds holding CAH
VCM
VPM
Hillsdale Investment Management's CAH Position: Q1 2026 in Review
Hillsdale Investment Management increased its Cardinal Health (CAH) stake by 18% in Q1 2026, buying an estimated $226K and bringing the position to 6,810 shares worth $1.44M. The position accounts for 0.04% of the portfolio, ranked #324.
Hillsdale Investment Management first reported a position in CAH in Q2 2013 and has held it in 32 quarters since. 1,431 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Hillsdale Investment Management held 6,810 shares of Cardinal Health worth $1.44M as of Q1 2026.
- Hillsdale Investment Management bought 1,050 Cardinal Health shares in Q1 2026, an estimated $226K.
- Cardinal Health made up 0.04% of Hillsdale Investment Management's portfolio in Q1 2026, its #324 holding.
- Hillsdale Investment Management first reported a position in Cardinal Health in Q2 2013 and has held it in 32 quarters since.
- 1,431 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.